Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP496028.RAcEbg-TfI-0Y6UbVuMlwU9vQ1BXFHlAU-JDdb5bMbWdM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP496028.RAcEbg-TfI-0Y6UbVuMlwU9vQ1BXFHlAU-JDdb5bMbWdM130_assertion type Assertion NP496028.RAcEbg-TfI-0Y6UbVuMlwU9vQ1BXFHlAU-JDdb5bMbWdM130_head.
- NP496028.RAcEbg-TfI-0Y6UbVuMlwU9vQ1BXFHlAU-JDdb5bMbWdM130_assertion description "[The expression pattern of the detected clones and their immunogenicity demonstrates that they might be relevant for the understanding of CTCL and suggests particularly three clones, HD-CL-41 (DRAK2), HD-CL-49 (nudC) and HD-CL-12 (ZNF195) for further analysis with respect to their prognostic and therapeutic value for CTCL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP496028.RAcEbg-TfI-0Y6UbVuMlwU9vQ1BXFHlAU-JDdb5bMbWdM130_provenance.
- NP496028.RAcEbg-TfI-0Y6UbVuMlwU9vQ1BXFHlAU-JDdb5bMbWdM130_assertion evidence source_evidence_literature NP496028.RAcEbg-TfI-0Y6UbVuMlwU9vQ1BXFHlAU-JDdb5bMbWdM130_provenance.
- NP496028.RAcEbg-TfI-0Y6UbVuMlwU9vQ1BXFHlAU-JDdb5bMbWdM130_assertion SIO_000772 17979976 NP496028.RAcEbg-TfI-0Y6UbVuMlwU9vQ1BXFHlAU-JDdb5bMbWdM130_provenance.
- NP496028.RAcEbg-TfI-0Y6UbVuMlwU9vQ1BXFHlAU-JDdb5bMbWdM130_assertion wasDerivedFrom befree-20140225 NP496028.RAcEbg-TfI-0Y6UbVuMlwU9vQ1BXFHlAU-JDdb5bMbWdM130_provenance.
- NP496028.RAcEbg-TfI-0Y6UbVuMlwU9vQ1BXFHlAU-JDdb5bMbWdM130_assertion wasGeneratedBy ECO_0000203 NP496028.RAcEbg-TfI-0Y6UbVuMlwU9vQ1BXFHlAU-JDdb5bMbWdM130_provenance.